According to a new market research study of ‘Thrombectomy Devices Market to 2027 – Global Analysis and Forecasts by Type, Application, and End User.’ The global thrombectomy devices market is anticipated to reach US$ 2,101.29 Mn in 2027 from US$ 1,282.07 Mn in 2018. The market is anticipated to grow with a CAGR of 5.9% from 2019-2027. The report provides the trends prevailing in the global thrombectomy devices market and the factors driving the market along with those that act as hindrances.
Neurological diseases are disorders of brain, spine, and the nerves connecting the earlier two as well as supplying oxygenated blood. The neurovascular systems are highly dependent on the continuous supply of oxygen and nutrients supplied by the arteries and veins. Therefore, a defect in the system can impair the function, and it may quickly become a life-threatening issue. Thrombosis has been increasing in diseases such as peripheral vascular, neurovascular, and other diseases.
Thrombosis is a biological response that is closely linked to cerebral aneurysms, which are balloon-like dilations of blood vessel walls, caused by the weakening of the wall layers. The prevalence of cerebral aneurysms has increased excessively across the globe. Approximately, 30,000 people in the US suffer from brain aneurysm rupture every year. The brain aneurysm breaks every 18 minutes, and the annual rate of rupture in the US is found close to 8–10 per 100,000 people. Moreover, peripheral vascular diseases (PVD) decrease the blood flow and affect blood vessels outside of the heart and brain, and the most commonly affected parts of the body are legs and feet. Thus, the increasing incidences of target patients and the severity of these conditions are likely to fuel the growth of the thrombectomy devices market during the forecast period.
Get PDF Sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001313/
Moreover, In January, 2019, Terumo Corporation, received the FDA Premarket Approval (PMA) for the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB System is a unique, single-device treatment solution for wide neck bifurcation aneurysms, which may account for up to 35% of all aneurysms. Thus, FDA approvals & product launches are expected to propel the growth of Thrombectomy Devices market over the forecast years
Market leaders are involved in product approvals and launches, which have promoted its growth. For instance, in September 2018, Penumbra launched with new technology Penumbra JET 7 and Penumbra JET D Reperfusion Catheters powered by the Penumbra ENGINE aspiration source in the stroke thrombectomy aspiration product line. The launch has enabled the company to offer to better innovative products in the market.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
